A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment
Article in Frontiers in Oncology (November 2022)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (November 2022)
Article in Leukemia Research (September 2022)
Article in International Journal of Hematology (January 2021)